Súčasné možnosti liečby infantilných hemangiómov

Translated title of the contribution: Current possibilities of infantile haemangioma treatment

V. Novotná, Andrea Kováčiková Curková, M. Šimaljaková, C. Gelmetti

Research output: Contribution to journalArticle


Propranolol as a pharmacological treatment of infantile haemangioma (IH) was first reported in 2008 and since then has become popular worldwide with positive clinical results and rare adverse events. IH became a new indication group for propranolol. Authors report a case of a 3-month-old child with a large infantile haemangioma of the face treated successfully with propranolol. In the submitted paper the recent knowledge about treatment of large IH with propranolol is reported, the probable mechanism of action and success of this treatment is documented in the case study.

Translated title of the contributionCurrent possibilities of infantile haemangioma treatment
Original languageCzech
Pages (from-to)79-82
Number of pages4
JournalCesko-Slovenska Dermatologie
Issue number2
Publication statusPublished - 2013


  • Infantile hemangioma
  • Pharmacological treatment
  • Propranolol

ASJC Scopus subject areas

  • Dermatology

Fingerprint Dive into the research topics of 'Current possibilities of infantile haemangioma treatment'. Together they form a unique fingerprint.

  • Cite this

    Novotná, V., Kováčiková Curková, A., Šimaljaková, M., & Gelmetti, C. (2013). Súčasné možnosti liečby infantilných hemangiómov. Cesko-Slovenska Dermatologie, 88(2), 79-82.